Hologic (HOLX)
(Delayed Data from NSDQ)
$75.93 USD
-0.61 (-0.80%)
Updated May 6, 2024 04:00 PM ET
After-Market: $75.93 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$75.93 USD
-0.61 (-0.80%)
Updated May 6, 2024 04:00 PM ET
After-Market: $75.93 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Zacks News
3 Discounted MedTech Stocks Poised for Sturdy Growth in 2024
by Riya Anand
Prestige Consumer Health (PBH), Quest Diagnostics (DGX) and Hologic (HOLX) are currently at discounted zone that are expected to provide long-term gains.
Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know
by Zacks Equity Research
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Hologic (HOLX) Q1 Earnings Might Rise on Breast Health Growth
by Zacks Equity Research
Strong performance in the Breast Health segment is likely to boost Hologic's (HOLX) Q1 result.
Why Hologic (HOLX) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Hologic (HOLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Hologic (HOLX) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Strength in Breast Health and GYN Surgical businesses are likely to contribute to Hologic's (HOLX) Q1 2024 revenues.
Hologic (HOLX) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the most recent trading session, Hologic (HOLX) closed at $72.89, indicating a +0.19% shift from the previous trading day.
Strength Seen in Intuitive Surgical, Inc. (ISRG): Can Its 10.3% Jump Turn into More Strength?
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Hologic (HOLX) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
Hologic (HOLX) closed at $72.12 in the latest trading session, marking a +1.11% move from the prior day.
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Generative AI Reshapes Healthcare: 3 Stocks in Limelight
by Zacks Equity Research
Stocks like Medtronic (MDT), Stryker (SYK) and NVIDIA (NVDA) are likely to benefit from the rising prospects of Generative AI in healthcare.
Hologic (HOLX) Increases Despite Market Slip: Here's What You Need to Know
by Zacks Equity Research
Hologic (HOLX) concluded the recent trading session at $72.46, signifying a +1.41% move from its prior day's close.
The Zacks Analyst Blog Highlights DaVita, GE HealthCare Technologies and Hologic
by Zacks Equity Research
DaVita, GE HealthCare Technologies and Hologic are part of the Zacks top Analyst Blog.
Hologic (HOLX) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
Hologic (HOLX) closed the most recent trading day at $70.94, moving -0.24% from the previous trading session.
3 Beaten-Down MedTech Stocks Poised for a Turnaround in 2024
by Debanjana Dey
Here are some dirt-cheap MedTech value stocks - DVA, GEHC, HOLX - which are expected to provide long-term gains.
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
3 MedTech Stocks With Potential to Benefit From AI Boom in 2024
by Indrajit Bandyopadhyay
Investors looking to tap the budding prospects in the lucrative AI market in 2024 can count on Medtronic (MDT), GE HealthCare Technologies (GEHC) and Hologic (HOLX).
Hologic (HOLX) Stock Moves -1.17%: What You Should Know
by Zacks Equity Research
In the most recent trading session, Hologic (HOLX) closed at $70.32, indicating a -1.17% shift from the previous trading day.
Here's Why You Should Retain Hologic (HOLX) Stock for Now
by Zacks Equity Research
Investors are optimistic about Hologic (HOLX), which is led by growth with recovery in procedural volumes and acceleration from new business lines.
Here's Why Hologic (HOLX) Gained But Lagged the Market Today
by Zacks Equity Research
Hologic (HOLX) reachead $71.09 at the closing of the latest trading day, reflecting a +0.08% change compared to its last close.
Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know
by Zacks Equity Research
Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
Hologic's (HOLX) Q4 Earnings Beat Estimates, Gross Margin Down
by Zacks Equity Research
Solid year-over-year growth in the Breast Health segment drives Hologic's (HOLX) Q4 performance.
Hologic (HOLX) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Hologic (HOLX) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Unveiling Hologic (HOLX) Q4 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for Hologic (HOLX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2023.